AMPH

Amphastar Pharmaceuticals, Inc.

AMPH · CIK 1297184 · Annual (10-K) · Last 8 years

Financial Trends

Revenue$720M
20182025
Net Income$98M
20182025
Operating CF$156M
20182025
Free Cash Flow$121M
20182025

Income Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Revenue$0.7B$0.7B$0.6B$0.5B$0.4B$0.3B$0.1B$0.1B
Cost of Revenue$0.4B$0.4B$0.3B$0.3B$0.2B$0.2B$0.2B$0.2B
Gross Profit$0.4B$0.4B$0.4B$0.2B$0.2B$0.1B$0.0B$0.0B
R&D Expense$0.1B$0.1B$0.1B$0.1B$0.1B$0.1B$0.1B$0.1B
SG&A Expense————————
Operating Income$0.1B$0.2B$0.2B$0.1B$0.1B$0.0B$-0.0B$-0.0B
Net Income$0.1B$0.2B$0.1B$0.1B$0.1B$0.0B$-0.0B$-0.0B
EPS (Basic)$2.10$3.29$2.85$1.88$1.30$0.03$-0.02$0.04
EPS (Diluted)$2.03$3.06$2.60$1.74$1.25$0.03$-0.02$0.04

Balance Sheet

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Total Assets$1.6B$1.6B$1.5B$0.7B$0.7B$0.6B$0.6B$0.5B
Current Assets$0.6B$0.5B$0.5B$0.4B$0.3B$0.3B$0.3B$0.2B
Cash & Equivalents$0.2B$0.2B$0.1B$0.2B$0.1B$0.1B$0.1B$0.1B
Total Liabilities$0.8B$0.8B$0.9B$0.2B$0.2B$0.2B$0.2B$0.1B
Current Liabilities$0.2B$0.2B$0.2B$0.1B$0.1B$0.1B$0.1B$0.1B
Stockholders' Equity————$0.4B$0.4B$0.4B$0.3B

Cash Flow Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Operating Cash Flow$0.2B$0.2B$0.2B$0.1B$0.1B$0.1B$0.0B$0.0B
Investing Cash Flow$-0.1B$-0.1B$-0.6B$-0.0B$-0.0B$-0.0B$-0.1B$-0.0B
Capital Expenditures$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Financing Cash Flow$-0.1B$-0.1B$0.5B$-0.0B$-0.0B$-0.0B$-0.0B$0.0B
← Companies